SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.

about

SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.

Item

http://www.wikidata.org/entity/Q47744121

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

SEOM/SERAM consensus statement ...... ollow-up in colorectal cancer.

@en

SEOM/SERAM consensus statement ...... ollow-up in colorectal cancer.

@nl

type

Item

label

SEOM/SERAM consensus statement ...... ollow-up in colorectal cancer.

@en

SEOM/SERAM consensus statement ...... ollow-up in colorectal cancer.

@nl

prefLabel

SEOM/SERAM consensus statement ...... ollow-up in colorectal cancer.

@en

SEOM/SERAM consensus statement ...... ollow-up in colorectal cancer.

@nl

P1476

SEOM/SERAM consensus statement ...... ollow-up in colorectal cancer.

@en

P2093

C Fernández-Martos

http://www.w3.org/2001/XMLSchema#string

E González-Flores

http://www.w3.org/2001/XMLSchema#string

E Parlorio

http://www.w3.org/2001/XMLSchema#string

F Matute

http://www.w3.org/2001/XMLSchema#string

F Rivera

http://www.w3.org/2001/XMLSchema#string

M Pagés

http://www.w3.org/2001/XMLSchema#string

M Á Corral

http://www.w3.org/2001/XMLSchema#string

R Bouzas

http://www.w3.org/2001/XMLSchema#string

R Vera

http://www.w3.org/2001/XMLSchema#string

P2860

Follow-up strategies for patients treated for non-metastatic colorectal cancer

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials.

Utility of reassessment after neoadjuvant therapy and difficulties in interpretation

Transrectal ultrasonography of anorectal diseases: advantages and disadvantages.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline.

How oncologists and their patients with advanced cancer communicate about health-related quality of life.

P2888

s12094-016-1518-9

P304

135-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-016-1518-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rocío García-Carbonero

P577

2016-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27206566

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer